These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2270377)

  • 1. [Conservative therapy of peripheral arterial occlusive disease].
    Frauchiger B
    Schweiz Rundsch Med Prax; 1990 Dec; 79(50):1560-3. PubMed ID: 2270377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of peripheral arterial occlusive disease with special reference to prostaglandins].
    Creutzig A
    Z Gesamte Inn Med; 1991 Mar; 46(3):59-67. PubMed ID: 1828125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment strategies in arterial occlusive diseases].
    Bollinger A
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1354-8. PubMed ID: 8272701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of peripheral arterial occlusive diseases. Round table conference].
    Bollinger A; Biland L; Brunner U; Kappert A; Krähenbühl B; Mahler F; Monti M; Nachbur B; Schneider E; Widmer LK
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1834-6. PubMed ID: 6233698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
    Lorenzen ND; Eldrup N; Laustsen J
    Ugeskr Laeger; 2007 Sep; 169(39):3279-82. PubMed ID: 17953885
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; ten Cate JW; Prandoni P; Simioni P; Andreozzi GM; Girolami A; Büller HR
    Eur J Vasc Endovasc Surg; 2000 Apr; 19(4):370-80. PubMed ID: 10801370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Large trials in the secondary prevention of stroke].
    Gensini GF; Simone I; Pantoni L; Inzitari D
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():102S-109S. PubMed ID: 9004808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use.
    Watson HR; Bergqvist D
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):445-50. PubMed ID: 10828222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventive treatment of cerebrovascular accidents of arterial origin].
    Castillo V; Bogousslavsky J; Vuadens P
    Praxis (Bern 1994); 1996 Feb; 85(6):159-63. PubMed ID: 8701178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty.
    Horrocks M; Horrocks EH; Murphy P; Lane IF; Ruttley MS; Fligelstone LJ; Watson HR
    Int Angiol; 1997 Jun; 16(2):101-6. PubMed ID: 9257670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern conservative therapy of arterial occlusive diseases].
    Schultz-Ehrenburg U
    Hautarzt; 1980 Aug; 31(8):419-27. PubMed ID: 7451147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy and behavioral intervention for peripheral arterial disease.
    Doyle J; Creager MA
    Rev Cardiovasc Med; 2003; 4(1):18-24. PubMed ID: 12684600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
    Marshall M
    Fortschr Med; 1982 May; 100(18):825-30. PubMed ID: 7095698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R; Bounameaux H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
    Halkes PH; Algra A
    Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.